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Abstract: The nsp3 macrodomain is implicated in the viral replication, pathogenesis and host immune responses through the removal
of ADP-ribosylation sites during infections of coronaviruses including the SARS-CoV-2. It has ever been modulated by macromolecules
including the ADP-ribose until Ni and co-workers recently reported its inhibition and plasticity enhancement unprecedentedly by
remdesivir metabolite, GS-441524, creating an opportunity for investigating other biodiverse small molecules such as β-Carboline
(βC) alkaloids. In this study, 1497 βC analogues from the HiT2LEAD chemical database were screened, using computational approaches
of Glide XP docking, molecular dynamics simulation and pk-CSM ADMET predictions. Selectively, βC ligands, 129, 584, 1303 and
1323 demonstrated higher binding affinities to the receptor, indicated by XP docking scores of –10.72, –10.01, –9.63 and –9.48 kcal/
mol respectively than remdesivir and GS-441524 with –4.68 and –9.41 kcal/mol respectively. Consistently, their binding free energies
were –36.07, –23.77, –24.07 and –17.76 kcal/mol respectively, while remdesivir and GS-441524 showed –21.22 and –24.20 kcal/mol
respectively. Interestingly, the selected βC ligands displayed better stability and flexibility for enhancing the plasticity of the receptor
than GS-441524, especially 129 and 1303. Their predicted ADMET parameters favour druggability and low expressions for toxicity.
Thus, they are recommended as promising adjuvant/standalone anti-SARS-CoV-2 candidates for further study.
Key words: SARS-CoV-2, nsp3 macrodomain, ADP-ribose, β-carboline, bioinformatics, drug design

1. Introduction
The non-structural protein 3 (nsp3) remains the largest
interactive protein complex of coronaviruses (CoVs)
with several macrodomains (Macs) located in the open
reading frame (ORF) 1ab. The first macrodomain (Mac1) encodes genome essential for the regulatory activity
of the host immune responses through the recognition
and removal of posttranslational adenosine diphosphate(ADP-)ribosylation specific sites during infection (Ni et
al., 2021). It is, therefore, implicated in the pathogenesis
and as a virulence factor in all forms of human CoV
infections (Alhammad et al., 2020). Several positivestranded genomic RNA viruses including the severe
acute respiratory syndrome coronavirus 1 (SARSCoV-1), Middle East respiratory syndrome coronavirus
(MERS-CoV) and SARS-CoV-2 exhibit the encoding

of a structurally conserved Mac-1 module that binds
and removes ADP-ribose (Lin et al., 2020; Ayipo et al.,
2021). The progression of the process induces pathogenic
disruption of the host innate immune system through
its mono(ADP-ribosyl) hydrolase activity, making an
inhibitory binding of bioactive scaffolds to its adenosyl
active pockets a prime therapeutic pathway (Cho et
al., 2016; Alhammad et al., 2020; Babar et al., 2020;
Brosey et al., 2021). These mechanistic posttranslational
modifications by nsp3 Mac-1 occurring as poly- or
mono-ADP-ribosylation (MARYlation) are catalysed by
several enzymes, notably, mono-ADP-ribosyl transferase
(MART), and are hypothetically associated with stress
expression and innate immune response against viral
pathogenesis. The activation of several poly-ADP-ribose
polymerases (PARPs) in response to molecular patterns
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and interferon pretreatments also support MARYlation as
an essential modification for the innate immune response
against viral infections, including the current pandemic,
coronavirus 2019 (COVID-19) (Challa et al., 2021; Ni et al.,
2021). Therefore, the associated expressions of the viral life
cycle (replication) and infection, as well as the deregulation
of host immune responses, make the nsp3 Mac-1 a
plausible therapeutic target for effective prophylaxis and
treatment of SARS-CoV infections. Moreover, structural
and experimental evidence strongly emphasize the
contributions of its plasticity to the development of potent
inhibitors. Notably, large bioactive molecules, including
ADP-ribose, have ever been commonly reported as an
ideal candidate for this prospect (Figure 1A). Other
potent inhibitors of the nsp3 Mac-1 of SARS-CoV-2 of
this type, including HEPES and MES8-4, have also been
reported (Brosey et al., 2021). From experimental reports,
other active biodiverse small molecules targeting Mac-1
of CoVs are suggested to possess interesting broad antiCoV activity (Cho et al., 2016; Alhammad et al., 2020).
Subsequently, some X-ray-resolved structures of the nsp3
Mac-1 of SARS-CoV-2 have been documented in Protein
Data Bank (PDB) in complexes with various naturally
occurring nucleosides and nucleotides (Figure 1B). A
recent comparative analysis of the complexes indicated
degrees of domain plasticity of the ADP-ribose binding
site of the target influenced by remdesivir metabolites, GS441524 and its phosphorylated derivative among the tested
small bioactive ligands. The intrinsic plasticity of amino
acid residues such as Ile131 and Phe132 in the ribosephosphate binding site supported by Ala129 and Gly130
main chain flips highly potentiate the availability of the
site for the binding of small molecules such as GS-441524
(Figures 1C-D) (Ni et al., 2021). Interestingly, remdesivir
and its GS-441524 metabolite were renown active inhibitors
of the viral replication through the RNA-dependent RNA
polymerase (RdRp). However, the experimental data in the
study by Ni et al., unprecedentedly indicates an improved
conformational complementarity with the binding pocked
in complex with GS-441524 compared to ADP-ribose and
suggests an enhanced plasticity of the nsp3 macrodomain
influenced by its structural and physicochemical features
(Ni et al., 2021). The interesting experimental results
obtained by the novel study provides an opportunity for
the investigation of other biodiverse small molecules as
plasticity enhancers and inhibitors of nsp3 macrodomain
of SARS-CoV-2.
β-Carboline (βC) alkaloids are structurally diverse
organic small molecules with tricyclic pyrido [3,4-b]
indole scaffolds. They exist in vast natural products
and as interesting synthetic analogues renowned to
medicinal chemists. Their structural features consist
of pharmacophoric sites favouring interaction with
various biological targets. As such, numerous molecular
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derivatives of βC analogues have been reported with
impressive pharmacology as antimicrobial, anticancer
and antiviral agents among others. Specifically, their
disruptive intercalating ability on DNA and/or RNA
support inhibitory potentials against tumour and viral
cells (Ayipo et al., 2021; Ayipo Y et al., 2021; Chakravarti
et al., 2021). Subsequently, the inhibitory effects of some
natural βC analogues have been documented against
some targets implicated in the pathogenesis and treatment
of COVID-19 including the viral main proteases, spike
glycoprotein, nsp9 and host angiotensin-converting
enzyme 2 (ACE2) as well as the transmembrane protease
serine 2 (TMPRSS2) (Chakravarti et al., 2021; Parmar et
al., 2021). Despite the impressive activity against other
CoV therapeutic targets, the evaluation of their potency as
promising anti-CoV agents specifically with mechanistic
inhibition and plasticity enhancement of nsp3 Mac-1
remains unreported from our findings.
The applications of computational tools such as
molecular docking, molecular dynamics and predictors
of physicochemical, pharmacokinetics and toxicological
profiles of drug-like candidates are not only powerful but
have become invaluable in modern drug designs. They have
been reported as faster, cost-effective and environmentally
friendly methods for identifying lead-like candidates for
further experimental study. The applications have been
reported with numerous successes leading to the discovery
of various FDA-approved medications (Meng et al., 2011;
Ruyck and Brysbaert, 2016; Phillips et al., 2018).
Thus, in this study, βC analogues were retrieved
from the HiT2LEAD chemical database and screened
for prospective inhibitors and plasticity enhancers of
SARS-CoV-2 nsp3 macrodomain, using computational
approaches of Maestro Glide XP docking, MD simulation
of Ligand and Receptor Molecular Dynamics (LARMD)
server-based software. The pharmacokinetics, druggability
and safety of the selected potentials were assessed about
remdesivir and its metabolite, GS-441524 using pk-CSM
ADMET predictions. The workflow is represented in
Figure 2.
2. Materials and methods
2.1. Ligand selection
The HiT2LEAD chemical database was searched for
substructures of βC alkaloids. The retrieved βC analogues
were downloaded in structure data files (SDFs) for the
study.
2.2. Ligand preparation
The SDF files of the retrieved βCs and remdesivir and
GS-441524 controls were imported into the workspace
of Maestro 12.12 (LigPrep, Schrodinger, LCC, New York,
NY, USA), followed by preparation through protonation,
energy minimization, and estimation of geometry and
partial atomic charges using optimized potentials for

AYIPO et al. / Turk J Biol

Figure 1. Illustration of the ADP-ribose binding pocket of nsp3 macrodomain of SARS-CoV-2. (A) Plasticity of the ADP-ribose binding
pocket; (B) Superimposition of eight molecules from the asymmetric units of two distinct apo crystal structures (PDBs 6YWK and
6YWM) (Reprinted with permission from (Ni et al., 2021), Copyright (2021) American Chemical Society; (C) 3D view of nssp3 Mac-1
in complex with G-441524 (PDB 7BF6); (D) Binding pose showing interactions of G-441524 with amino acids at the active ADP-ribose
binding site.

liquid simulations 3e (OPLS-3e) force field (Harder et al.,
2016). The default Epik at a target was set at pH 7.0 ± 2.0
to generate possible ionization states and the minimized
conformers, saved in LigPrep.out file.
2.3. Protein preparation, binding site analysis and generation of the receptor grid box
The PDB format of the crystal structure of SARS-CoV-2
macrodomain in complex with remdesivir metabolite,
GS-441524, expressed in Escherichia coli (PDB 7BF6)
was retrieved from RCSB PDB. It was preprocessed
by assigning bond order, protonation states and filling
missing loops using Protein preparation wizard (Madhavi
et al., 2013). Further preparation was then followed by
optimization, refining and energy minimization for the
conversion of heavy atoms to relative mean standard
deviation (RMSD) 0.3 using the OPLS-3e force field of

Maestro 12.12 (Harder et al., 2016). The enclosing grid
box for docking was generated by selecting the centroid
of the workspace GS-441524 with x, y and z coordinates of
19.07, –2.54 and 3.83, respectively and default settings of
the ligand docking length within 20 Å, saved in gridbox.
zip file.
2.4. Molecular docking
The ligand-receptor docking simulation was employed
to virtually evaluate the inhibitory potentials of the 5191
conformers of βC analogues and reference drugs (positive
controls) generated from the LigPrep module against the
prepared file of SARS-CoV-2 nsp3 macrodomain (PDB
7BF6). Both the receptor grid zip and ligand output files
were uploaded in the Maestro 12.2 Glide docking panel
for XP ligand-receptor docking simulation (Halgren et al.,
2004). The choice of XP module provides an opportunity
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Figure 2. Workflow of the study.

for more discriminate, robust torsional refinement and
ligand sampling, though it’s more time-consuming and it
requires highly configured computing resources (Parmar
et al., 2021). The precision, accuracy and reproducibility
of the docking protocol were validated through redocking
of the co-crystallized ligand within the active pocket of
the receptor and computing its RMSD in comparison with
the retrieved crystal complex from RCSB PDB. An RMSD
value of ≤2.0 Å validates the protocol as good (CastroAlvarez et al., 2017; Ramírez and Caballero, 2018). The
docked ligands were ranked based on the algorithms of
docking and glide XP scores, while their interactions with
amino acid residues in the active binding pocket of the
receptor were analysed using the generated 2D binding
poses.
2.5. Molecular dynamics
The binding energy, stability and flexibility trajectories
of the selected ligand-receptor complexes were evaluated
using molecular mechanics (MM) force field in LARMD
server-based software integrated with AMBER 16 force
field (Yang et al., 2019). The PDB file of each complex
system was uploaded for ‘Int-mod’ simulation with default
all-atom MD set at 3000 ps, water implicit. The statistics
of the H-bonding plot indicates the H-bond contacts that
occurred between the ligands and amino acid residues
during the simulation. The deviation of the average
distance of the atoms of the docked ligands from their
original positions was displayed by RMSD plots, while the
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radius of gyration reveals the RMS average of the distance
of all atoms of the receptor/ligand from the centre of mass.
The possible conformational dynamics of each molecular
complex system and energetics of the binding of ligands
were assessed by capturing the transition states of the
receptor with a folding free energy barrier, represented
by the fractions of native contacts. The fluctuations and
isotropic displacements that occurred on each amino
acid residue along the simulation trajectories were
represented by the RMS fluctuation (RMSF) and B-factor
plots. Molecular mechanics generalized born surface area
continuum solvation [MM/GB(SA)] re-scoring methods
and the statistics of hydrogen bonds between the bound
ligands and the protein residues depict the ligand-receptor
binding affinities and free energies. The MM/GB(SA) was
calculated as ΔGbind in the equations below:
ΔGbind = Gcomplex – Greceptor – Gligand		
= ΔH - TΔS ≈ ΔEgas + ΔGsol + TΔS

(i)
(ii)

ΔEgas = ΔEint + ΔEele + ΔEvdw

(iii)

ΔGsol = ΔGGB + ΔGsurf 			

(iv)

where ΔEgas is the gas-phase energy change, ΔEint represents
the change in internal energy, ΔEele is the electrostatic
force, ΔEvdw is the change in van der Waals forces, ΔGsol is
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the solvation free energy, while ΔGsurf represents the nonpolar contribution to the solvation-accessible surface area
(Genheden and Ryde, 2015; Wang et al., 2019; Babar et al.,
2020). The βC ligand with the highest stability and ability
to induce plasticity when in complex with the receptor
target was further subjected to the CABS-flex molecular
dynamics module in comparison with GS-441524. The
server-based software incorporates a knowledge-based
force field and stochastic dynamics of the Monte Carlo
method to predict models and trajectories to indicate the
flexibility of the protein structure (Jamroz et al., 2013).
To further study the dynamic evolutions of the
ligands and their long time stability in the active binding
pocket of the receptor as well as the change in protein
structure within a solvent system, 20 ns MD simulation
was conducted for ligands 129 and 1303 complexes using
the academic version of Desmond 2020-3 (MaestroDesmond Interoperability Tools, Schrödinger, New York,
NY, USA). The solvated system was modelled using the
System Builder panel. Each ligand-receptor complex
was centred in an orthorhombic cubic box with periodic
boundary conditions and filled with Single-point charge
(SPC) water molecules buffered at a minimum distance of
10 Å between a protein atom and box edges. The system
was neutralized by randomly adding a sufficient number
of counter-ions (Na+ and Cl−), and an isosmotic state
was maintained by adding 0.15 M NaCl. It was thereafter
minimized and relaxed by OPLS 2005 force field, keeping
other parameters of Desmond at default (Ahmad et al.,
2021; Jorgensen et al., 1996; Patel et al., 2021). The MD
simulations were carried out using an isothermal-isobaric
(NPT) ensemble with 300 K temperature, 1 atm pressure,
and a 200 ps thermostat relaxation period. A total number
of 1000 trajectories were produced within the 20 ns
period, and then analysed using the simulation interaction
diagram (SID) tool (Kalibaeva et al., 2003; Patel H et al.,
2021).
2.6. In silico pharmacokinetics, druggability and toxicological assessment
Physicochemical, pharmacokinetics and pharmacodynamics
parameters crucial to the delivery of drugs to targets for
physiological expressions without significant toxicity
were predicted for the selected βCs using the pkCSMpharmacokinetics server by the input of a string of
SMILE files. The module incorporates distance-based
graph structural signatures through accurate and precise
calculations of atomic pharmacophore frequency counts,
toxicophore fingerprints and general molecular properties
of novel candidates (Pires et al., 2015). The parameters,
including molecular weight (MW), lipophilicity (Log
P), solubility (Log S), number of hydrogen bond
acceptor/donor (HBA and HBD), number of rotatable
bonds (flexibility), Log P, topological polar surface area
(TPSA) were quantitatively predicted to profile their

absorption, distribution, metabolism, excretion and
toxicity (ADMET). The druggability of the selected βCs
was also determined using the potentials for blood-brain
barrier (BBB), p-glycoprotein (pg) substrate, human
gastrointestinal absorption and the inhibitory potentials
on cytochrome P450 isoenzymes. The parameters were
referenced to the BDDC rules of 5 (RO5) and druggability
(Benet et al., 2016).
3. Results and discussion
3.1 Ligand selection and preparation
The search on Cambridge online chemical database,
HiT2LEAD
(https://www.hit2lead.com)
for
βC
substructures produced 1497 bioactive analogues, which
generated 5191 ready-to-dock protonated conformers.
3.2. Molecular docking
The computational evaluation of the potentials of the
prepared 5191 βC ligands to inhibit the nsp3 macrodomain
of SARS-CoV-2 in references to remdesivir and GS441524 as described in the experimental section produced
the docking results. The redocking of the co-crystallized
GS-441524 with the active pocket of the crystal structure
PDB 7BF6 generated a pose with an RMSD of 0.51 Å, and
the ligand was retrieved among the five best docked poses
as expected. The binding interaction shown by the docked
ligand was similar to the reported ligand interaction in the
RCSB PDB for the receptor, thereby validating the docking
protocols as reliable (Castro-Alvarez et al., 2017; Ramírez
and Caballero, 2018). From the results (Table 1), it could
be observed that four βC analogues 584, 1323, 129 and
1303 orderly show higher binding affinity, a potential
for stronger binding inhibitory actions than remdesivir
and its metabolite GS-441524, as indicated by docking
score and XP GScore. According to Ni et al., the apo
state crystallization of the macrodomain produced two
different orthorhombic crystals of the receptor with three
and five molecules respectively in the asymmetric units,
contributed by Leu131 and Phe132. These potentiate the
plasticity of the receptor and favour the binding of small
molecules. Additionally, Asp22, Ala38, Val49, Leu126,
Leu131, Phe132, Val155, Phe156 and Asp157 reportedly
constitute the active binding pocket of the receptor
for pharmacologically inclined interactions (Babar et
al., 2020). From the crystal structure (PDB 7BF6), the
binding of GS-441524 as a small molecule is similar to
that of ADP-ribose, where its NH group is sandwiched
between Val49 and Val155, forming H-bonding to Asp22.
Similar H-bonding interaction was observed in this
simulation through OH to Leu126 and weak interactions
to backbone Phe156 and Asp157 residues. These confer
charge compatibility by its nitrile group with the receptor
pocket. From a previous study, GS-441524 was recorded
as most successful among the tested antivirals including
remdesivir and its contributions to the plasticity of the
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Table 1. Binding affinity of selected βC analogues to SARS-CoV-2 nsp3 macrodomain
(PDB 7BF6).
VW

GE

GBS

MMGB(SA)
kcal/mol

Title

XP GScore EE

GBT

TS

584

–10.72

–2.60 –55.58 –58.35 12.91

–45.44

9.37 -36.07

1323

–10.01

11.67 –27.68 –6.00

129

–9.63

–2.75 –34.45 –37.20 6.60

–13.58 –19.59

5.82 –23.77

1303

–9.48

37.35 –46.29 –8.95

GS-44

–9.41

–5.78 –39.88 –45.65 12.07

–33.59

9.59 –24.00

Remde. –4.68

–9.30 –49.38 –58.77 17.68

–31.08

9.86 –21.22

–30.60

6.53 –24.07

–14.77 –23.71

5.95 –17.76

See supplementary file 1 for complete docking results. GS-44 = GS-441524; Remde =
Remdesivir; EE = Electrostatic energy; VW = van der Waals contribution; GE = total
gas-phase energy; GBS = GB contribution to solvation; GBT = GB total; MMGB(SA)
= final binding free energy.

receptor as well as inhibitory potentials as promising antiSARS-CoV-2 were confirmed upon biochemical analyses
(Ni et al., 2021). The binding pose of the redocked GS441524 with the same receptor in this study (Figure 1D)
shows similar patterns of bonding and non-bonding
interactions, strengthening the reliability of the present
findings. The binding poses of selected βC ligands 584,
1323, 129 and 1303 against the same receptor are shown
in Figure 3. As observed with GS-441524 reference, all
the selected βC ligands formed hydrophilic H-bonding
interaction with Leu126 through NH or C=O group
except 129. The ligand with the highest docking score,
584 also interacted with Val49, Ala38 and Ala129 all
through H-bonding to NH or C=O group. Ligand 1323
additionally formed strong H-bonding interaction to
the backbone amino acid residues, Phe156 and Asp157,
conferring higher compatibility with the receptor pocket
compared to GS-441524 where the interactions were
observably weak (Ni et al., 2021). In similarity to ADPribose and GS-441524, ligand 129 also show H-bonding
interaction to the amino acid Asp22, sandwiched between
Val49 and Val155. The selected ligands demonstrate
similar pharmacological potentials to ADP-ribose and GS441524 through binding interactions with the conserved
amino acid residues for specificity of the receptor. They
demonstrate higher binding affinity than GS-441524 and
impressively pose as small molecule inhibitors of nsp3
macrodomain for further analysis. Since the proteinligand binding interactions are crucial for drug actions
(Klebe, 2013), the selected compounds as well as the
references were subjected to MD simulations for further
study of molecular interactions with the receptor.
3.3. Molecular dynamics
The flexibility and thermodynamic stability of the selected
ligands in complex with the receptor were virtually studied
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using MD simulations, an indispensable tool for biophysical
and structural probes (Lynch et al., 2017). As observed in
Table 1, the total binding free energy, MMGB(SA) deduced
by a sum of GBT and TS comprehensively quantify the
interactions existing between the selected βC ligands and
the SARS-CoV-2 nsp3 macrodomain through various
conformations. The results of binding free energies of the
selected βC ligands are mostly higher (negative values) than
remdesivir and GS-441524, consistently with the docking
scores except for 1303. The statistics of H-bond (Figure
4A) indicates that the remdesivir and its metabolite, GS441524 exhibited a higher number of H-bond contacts
than the selected βC ligands during the simulations. This
should have accounted for higher binding affinities to the
receptor especially for GS-441524 as reported (Ni et al.,
2021) than the βC ligands; however, the affinity-inclined
contributions of other complementary hydrophilic/
hydrophobic bonding and nonbonding interactions to
the polar and non-polar amino acid residues, respectively,
cannot be overruled. The emphasis on these interactions
is essential for their promising druggability (Klebe, 2013).
The RMSD plots (Figure 4B) show that the receptor
backbone initially experienced a slight atomic deviation
of 0.5–1.0 Å and became equilibrated around 100 ps and
subsequently with an insignificant deviation of <1.0Å until
the end of the simulation in all cases. This supports that
the 3500 ps selected for the simulation is adequate for
the tentative assignment. The selected βC ligands mostly
entered the equilibrium condition around the same time
and maintained stability throughout the simulations with
insignificant deviations except 1323. Averagely, good
thermodynamic stabilities were observed for 584, 129
consistently with the reference GS-441524.
The dynamic thermal motion paths, mean square
isotropic displacements and transient channels, which
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Figure 3. Binding poses showing interactions of selected βC ligands with conserved amino acid residues in the
active pocket of SARS-CoV-2 nsp3 macrodomain (PDB 7BF6). Interactions are shown as hydrogen bonding
(magenta arrow), π - cation (blue line), salt bridge (red line) and π - π stacking (green line).

support the ligands to enter the internal binding cavities
of the receptor are represented by B-factor or temperature
factor (Figure 5A) and RMSF plots (Figure 5B). The

amino acids with residue numbers 14, 33, 90, 120 and
146 showed the highest fluctuation (between 19 – 21
Å). Although all the selected βC ligands including the
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Figure 4. Molecular dynamic simulation trajectories: (A) Statistics of H-bond contacts between the ligands and amino acid residues in
the receptor; (B) RMSD of the receptor backbones and the ligands.

references experienced very insignificant fluctuations
in complexity with the receptor; however, 129 and 1303
displayed the highest stability indicated by diminutive
fluctuation similarly to remdesivir but in better forms
than GS-441524. Since plasticity significantly influences
thermodynamic stability, resistance to change in
environment and the binding/interaction potentials of
protein receptors to ligands, it could be inferred that the
enhanced thermodynamic stability observably influenced
by the βC ligands support their propensity to enhance the
plasticity of the SARS-CoV-2 nsp3 macrodomain as small
molecules. These interestingly contribute to the integrity
and the predisposition of the target in the pathogenesis
of SARS-CoV-2 infection (Panja et al., 2020). To further
probe the structure-related influences of the ligands, the
compactness and stability of the selected ligand-receptor
complexes were observed through the radius of gyration
(Rg) plot (Figure 5C). The Rg is determined by the folding
state of protein receptors in complexes with the ligands
along the trajectories of simulations. All the selected
βC ligands, as well as drug references, are favoured by
good compactness and stability as indicated by the plot;
however, 584 slightly seem perturbed towards the end
of the simulation. The native contacts, which capture
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the transition states between the selected ligands, as well
as the reference drugs and the receptor with a folding
free energy barrier, indicate the thermostability of the
complexes. A system comprising of an unfolding protein
is indicated by a large fluctuation in Q (X). Considering
the result (Figure 5D), the βC ligands, 1303, 129 and 1323
displayed the least change in Q in the order compared
to remdesivir and GS-441524, although they all show
good stability overall. Thus, selected βC ligands mostly
show better contact with the receptor in folding state
along the simulations, indicating potentials to influence
the flexibility and plasticity of the receptor for binding
to small molecule drugs. Since the stability of a protein is
dependent on its structural plasticity (Panja et al., 2020),
cumulatively, selected βC ligands, especially 1303 and 129
show ideal flexibility, good stability and abilities to enhance
the plasticity of the SARS-CoV-2 nsp3 macrodomain for
binding to drug molecules in stronger terms than GS441524. Further analyses of the ligand-induced stability
and plasticity of the receptor target carried out to compare
the impacts of 129 and GS-441524 using CABS-flex
server showed a reduced RMSF when the receptor was in
complex with 129 (Figure 5E) compared to the complex
involving GS-441524 (Figure 5F). This also supports the
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stronger influence of the βC ligands on the stability and
plasticity of the receptor compared to GS-441524 (Jamroz
et al., 2013; Tahir ul Qamar et al., 2021).
Upon the extension of MD simulation trajectory to
20 ns for the complexes of ligands 129 and 1303, slight
fluctuations within RMSD of 1-3 Å were observed

throughout, indicating stable systems (Ahmad et al., 2021;
Patel et al., 2021). The Apo protein simulation shows a
RMSD range of 1.0 to 1.5 Å (Figure 6), suggesting a good
protein stability. The RMSD plot of ligand 129 in complex
with the receptor (Figure 7A) indicates a fluctuation of
2.0 Å from the starting position till around 6 ns of the

Figure 5. Molecular dynamics simulation results for the selected ligands in complexes SARS-CoV-2 nsp3 macrodomain. (A) The B-/
temperature factor of the selected βC ligands, remdesivir and the GS441524. The lowest fluctuations (Å) are observed with 1303 and 129,
indicating the highest stability; (B) RMSF plot of the selected βC ligands and the references. Lower fluctuations are also demonstrated
by βC ligands similarly to B-factor, inferring higher stability; (C) Plots of the radius of gyration ligand-receptor complex system. Lower
fluctuations indicate more compactness and stability of the ligand-receptor system, relatively favouring βC ligands; (D) Native of contact
and (Q) of the ligand-receptor complex. The larger the variations in Q, the more the rigidity of the receptor which is unfavourable for
biological functions, especially involving binding of small molecule drugs. The selected βC ligands were also favoured relatively to
remdesivir and GS-441524. (E) CABS-Flex RMSF of 129; (F) CABS-Flex RMSF of 129, indicating a reduced RMSF when the receptor
was in complex with 129 compared to the complex involving GS-441524.
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trajectory, which is the highest for the ligand and 1.6 Å for
the protein, supporting a stable ligand-protein complex.
The RMSF value of the protein backbone residues occurred
within 1.2 to 1.6 Å in the catalytic domain, showing a
slightly high fluctuation in the C- and N- terminal in
contrast to regions of the protein (Figure 7B). During the
simulation, the oxygen of ligand 129 accepts hydrogen
from Ile23 for 99% of the simulation, whereas the nitrogen
of the imidazole group donates hydrogen to Ala154 for
92% of the simulation (Figure 7C). Amino acid residues
Asp22, Ile23, and Ala154 exhibited significant hydrogen
bonding to ligand 129, played essential roles at the binding
pocket, and were considered vital for stabilizing the hit
molecules. The amino acid residues, Ala38, Val49, Ala52,
Pro125, Leu126, Ala129, Ile131, Phe132, Phe156, and
Leu160 showed hydrophobic interaction to 129 (Figure
7D). Similar behaviour was observed with ligand 1303 with
RMSD of the Cα backbone (blue) observed between 0.6 to
1.6 Å, and RMSF of 1.2 to 1.6 Å (Figures 8A and 8B). The
pyridine-dione carbonyl groups of 1303 primarily interacts
with Leu126 through hydrogen bonding and Phe156 via
water mediated hydrogen bonding for 98% and 44% of
the simulation, respectively (Figure 8C). The histogram
depicting the nature of interactions that the protein makes
with ligand 1303 throughout the simulation reveals strong
hydrogen bonding with Ala38, Val49, Leu126, and Ala154
residues (Figure 8D). The complexes of the SARS-CoV-2
macrodomain and ligand 129 and 1303 were considered
to be stable, and the ligands remained within the receptor
active pocket throughout the 20 ns simulation.
3.4. In silico pharmacokinetics, druggability and toxicological assessment
Physicochemical, pharmacokinetics and pharmacodynamics
parameters are crucial to the delivery of drugs to targets
for physiological expressions without significant toxicity.
The adopted pk-CSM in silico module was validated
with several reported experimental results with good

accuracy and precision for predicting novel chemical
molecules comparable to the time-consuming and
expensive experimental modules (Pires et al., 2015). The
physicochemical and ADMET properties of the selected
βC ligands, GS-441524 and remdesivir are presented in
Table 2. The selected ligands have MW in the range of
150–500 g/mol, Log P within the range between –0.7 and
+5.0, rotatable bonds between 1–3, <10 HBA, <5 HBD
and TPSA 20–130 Å2. These physicochemical parameters
indicate that the selected ligands have ideal flexibility,
lipophilicity, size, solubility, saturation and polarity for
good pharmacokinetics of lead-like drug candidates
(Pires et al., 2015; Daina et al., 2017). The selected ligands
satisfy the BDDC rule of 5 and druggability (Benet et
al., 2016). The enhanced flexibility of the selected βC
ligands traceable to their number of rotatable bonds could
induce more conformational plasticity on the SARSCoV-2 nsp3 macrodomain than GS-441524 upon binding
(Anderson et al., 2001). The ligands and the references are
all predicted with good solubility and low permeability
across the human intestinal epithelial Caco-2 cell except
129. The selected βC ligands displayed higher intestinal
absorption than remdesivir and GS-441524. They mostly
demonstrated no substrate expression for P-glycoprotein,
a biological barrier by xenobiotics and extruding toxins,
consistently with the references. Their low permeability
across the BBB and the central nervous system (CNS)
indicate their unideal potentials for CNS drugs, which are
unimportant in this particular prospect (NaAllah et al.,
2021). Only 1323 showed no expression for metabolisminclined cytochrome P450 isoenzymes (CYPs) 2D6 and
3A4, similarly to GS-441524. They generally signalled
good propensity for excretion and low expressions
across several pathways for toxicity including hERG I
& II inhibition, AMES, Tetrahymena Pyriformis, and
minnow toxicity. Overall, the predicted physicochemical,
pharmacokinetics and pharmacodynamics properties

Figure 6. Time-dependent Apo protein RMSD (Å).
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Figure 7. (A) RMSD (Protein RMSD is shown in grey while RMSD of 129 are shown in red) (B) RMSF and (C) 2d contact summary (D)
Protein–ligand contact analysis of MD trajectory for 129 complex system.

Figure 8. (A) RMSD (Protein RMSD is shown in grey while RMSD of 1303 are shown in red). (B) RMSF and (C) 2d contact summary,
(D) Protein–ligand contact analysis of MD trajectory for 1303 complex system.
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Table 2. ADMET properties of selected βC ligands and references.
Property

Descriptor

129

584

1303

1323

GS441525 Remdesivir

MW

(g/mol)

292.338 364.453 324.384 321.384 291.267

602.585

Log P

-

3.0328

3.9239

1.38462 1.6627

–1.85672

2.31218

#Rot. bonds -

3

2

3

1

2

13

#HBA

-

2

3

4

3

9

13

#HBD

-

2

3

2

3

4

4

TPSA

(Å)

127.658 157.105 138.295 138.822 118.370

242.488

Absorption

Solubility (mol/L)

–3.57

–3.256

–3.679

–2.826

–2.482

–3.07

Absorption

Caco2 permeability

1.328

0.69

0.765

0.49

0.622

0.635

Absorption

Intestinal (%)

92.866

93.626

95.661

95.783

54.244

71.109

Absorption

Log Kp

–2.773

–2.736

–2.781

–2.735

–2.738

–2.735

Absorption

P-glycoprotein substrate

Yes

Yes

Yes

Yes

No

Yes

Absorption

P-glycoprotein I inhibitor

No

No

No

No

No

No

Absorption

P-glycoprotein II inhibitor

No

Yes

Yes

No

No

No

Distribution VDss (human)

–0.078

–0.254

0.683

–0.051

–0.262

0.307

Distribution Fraction unbound

0.04

0.159

0.425

0.437

0.614

0.005

Distribution BBB permeability

0.134

–1.353

–0.852

–1.077

–1.018

–2.056

Distribution CNS permeability

–2.046

–2.129

–2.452

–2.495

–3.699

–4.675

Metabolism CYP2D6 substrate

Yes

Yes

Yes

No

No

No

Metabolism CYP3A4 substrate

Yes

Yes

Yes

No

No

Yes

Metabolism CYP1A2 inhibitor

Yes

Yes

Yes

Yes

No

No

Metabolism CYP2C19 inhibitor

Yes

Yes

No

No

No

No

Metabolism CYP2C9 inhibitor

No

Yes

No

No

No

No

Metabolism CYP2D6 inhibitor

No

No

No

No

No

No

Metabolism CYP3A4 inhibitor

Yes

No

No

No

No

No

Excretion

log mL/min/kg)

0.353

0.079

0.996

1.342

0.513

0.198

Excretion

Renal OCT2 substrate

No

No

Yes

Yes

No

No

Toxicity

AMES toxicity

Yes

No

No

Yes

No

No

Toxicity

Max. tolerated dose (log mg/kg/day)

0.172

0.468

-0.336

0.494

0.718

0.15

Toxicity

hERG I inhibitor

No

No

No

No

No

No

Toxicity

hERG II inhibitor

Yes

Yes

Yes

Yes

No

Yes

Toxicity

Oral Rat Acute Toxicity (LD50) (mol/kg)

2.802

2.709

2.434

2.504

2.939

2.043

Toxicity

Oral Rat Chronic Toxicity (LOAEL) (mg/kg/day) 1.718

2.71

1.629

2.598

3.102

1.639

Toxicity

Hepatotoxicity

Yes

Yes

Yes

No

Yes

Yes

Toxicity

Skin Sensitisation

No

No

No

No

No

No

Toxicity

T. Pyriformis toxicity (µg/L)

0.701

0.286

0.433

0.285

0.284

0.285

Toxicity

Minnow toxicity

3.179

3.823

3.99

2.901

3.306

0.291

2

Hint: MW = molecular weight; HBA = H-bond acceptor; HBD = H-bond donor; TPSA = topological polar surface area

fall within the standards (Pires et al., 2015; Daina et al.,
2017) and support their promising potentials as druggable
candidates. Although the selected βC ligands mostly
demonstrated unimpressive expression to some CYP
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enzymes along the metabolic pathways, their general
toxicity is comparable to the reference drugs.
From the screened 1497 βC analogues of Hit2LEAD
chemical database, four (4) βC selectively demonstrate
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Figure 9. Chemical structures of finally identified βC ligands with potentials for plasticity enhancement and inhibition of nsp3
macrodomain of SARS-CoV-2.

promising potentials for enhancing the structural plasticity
and inhibiting the nsp3 macrodomain of SARS-CoV-2
in higher terms than remdesivir and GS-441524. They
also displayed good physicochemical, pharmacokinetics
and pharmacodynamics properties, supporting their
druggability with high expression for safety consistently
with the reference drugs. More interestingly, the βC
alkaloids are vast in natural products across the globe and
renowned to scientists with good synthetic accessibility.
Experimental validations are required to confirm their
bona fide potentials in future studies. However, the selected
βC ligands (Figure 9) represent promising candidates
for development as adjuvant or standalone therapeutics
for effective prophylaxis and treatment of COVID-19
and other emerging strains with mechanistic plasticity
enhancement and inhibition of the nsp3 macrodomain
target upon further study.
4. Conclusion
The nsp3 macrodomain is strongly implicated in viral
replication, host immune response and other pathogenesis
of CoV infections including the current COVID-19, as
such, represents an important therapeutic target. In this
study, computational approaches including molecular
docking and molecular dynamics were employed to screen
1497 βC alkaloids from the HiT2LEAD chemical database
for prospective inhibitors and plasticity enhancers. Taking
advantages of the comprehensive analyses reported against
the activity of GS-441524; four βC alkaloids, annotated as
129, 584 1303 and 1323 were identified with interesting
potentials to induce more conformational plasticity and
inhibition on the nsp3 macrodomain target of SARS-CoV-2
than GS-441524 along the pharmacological pathway.

Selectively, ligands 129 and 1303 possess physicochemical
properties that support higher level of stable interactions
as inhibitors of the receptor than GS-441524. Impressively,
they demonstrated good pharmacokinetics and
druggability with low expression for toxicity compared
to remdesivir and GS-441524. The results obtained are
comparable to the reported literature in favour of GS441524, which has been validated experimentally. This
significantly builds confidence for embarking on a further
rigorous experimental investigation of the few identified
βC prospects. The ligands are, therefore, recommended
as promising anti-SARS-CoV-2 small molecules targeting
the nsp3 macrodomain for further translational study.
However, further biochemical tests of the molecules
suggested as drug candidates in this study should be
performed. In conclusion, this study models a faster, costeffective and environmentally friendly approach to identify
promising candidates recommended for translational
study into anti-SARS-CoV-2 therapeutics.
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